The decision to license or sell a drug depends on profitability, strategic mission, and whether a company “believes” in the science of a drug.

May 10, 2023

"If you combine multiple diseases into a single financial portfolio, all of a sudden the risk-reward trade off becomes more attractive."

Feb 16, 2023

"We need the private sector to put in billions to match the hundreds of millions that the government has dedicated to this effort."

Aug 10, 2022

"We all want to have impact. But very few economists are able to do anything that would actually affect patient lives."

Aug 2, 2022